Cancer Immunology and Immunotherapy
Graduate School of Health and Medical Sciences at University of Copenhagen
This course is free of charge for PhD students at Danish universities (except Copenhagen Business School), and for PhD Students from NorDoc member faculties. All other participants must pay the course fee.
Anyone can apply for the course, but if you are not a PhD student at a Danish university, you will be placed on the waiting list until enrollment deadline. This also applies to PhD students from NorDoc member faculties. After the enrollment deadline, available seats will be allocated to applicants on the waiting list.
Learning objectives
A student who has met the objectives of the course will be able to:
1. Understand how the human immune system interact and shape the phenotype of cancer
2. Gain in depth knowledge on the methodologies used to study the immune response to cancer
3. Understand how cancer immunotherapies work in the clinical setting
4. Critically evaluate novel therapeutic approaches using the immune system to combat cancer
5.
Content
The course covers all the main aspect of cancer immunology and immunotherapy, from the bench to the bedside. The focus of the course shifts between day 1-2, where basic and translational research are the main topics, to day 3-4 where the application of this knowledge in the clinic is presented. Day 1-2, are focused on the main aspects of the generation of immune response to cancer, avoidance of immune destruction, immune targets on cancer cells, how to evaluate immune response to cancer, how to apply this knowledge to develop novel treatments. Day 3-4 are mainly dedicated to the application of cancer immunotherapy in the clinical arena to cover both clinical research and real-wold application of cancer immunotherapies in modern health systems, from a clinician and a patient's perspective. Day 4 will include specific sessions to facilitate knowledge sharing between the students and the main course supervisors, and an exercise about designing a cancer immunology or immunotherapy research program.
Day 5 will be dedicated to the international expert talks, including a clinical-translational workshop, based on topics discussed in day 1-4.
Participants
The course is relevant for PhD students who work on cancer or immunology related PhD projects, and aim to broaden their knowledge on basic, translational and clinical aspects of cancer immunology research. As such, PhD students engaged in basic, applied, and clinical cancer research projects are all welcome.
Relevance to graduate programmes
The course is relevant to PhD students from the following graduate programmes at the Graduate School of Health and Medical Sciences, UCPH:
Clinical Cancer Research Immunology and Infectious Diseases Cellular and Genetic Medicine
Language
English
Form
Lectures, group works and exercises.
Course director
Marco Donia, MD, PhD, Clinical Associate Professor, CCIT-DK, Herlev Hospital. marco.donia@regionh.dk
Teachers
Per thor Straten, Professor, CCIT-DK, Herlev Hospital Mads Hald Andersen, Professor, CCIT-DK, Herlev Hospital Information on the previous course:
https://phdcourses.ku.dk/DetailKursus.aspx?id=110562&sitepath=SUND
Dates
April 7-11, 2025
Course location
Day 1-4: Herlev Medborgerhus, Herlevgårdsvej 18, 2730 Herlev (https://maps.app.goo.gl/w8vzVGtD3v9RwHdF6)
Day 5: Herlev Hospital, Borgmester Ib Juuls Vej 1, 2730 Herlev (https://maps.app.goo.gl/w5QUHMBgr7kTpGeRA)
Registration
Please register before January 12th, 2025
Expected frequency
Every 18 months
Seats to PhD students from other Danish universities will be allocated on a first-come, first-served basis and according to the applicable rules.
Applications from other participants will be considered after the last day of enrolment.
Note: All applicants are asked to submit invoice details in case of no-show, late cancellation or obligation to pay the course fee (typically non-PhD students). If you are a PhD student, your participation in the course must be in agreement with your principal supervisor.